Literature DB >> 21036378

Randomised trial of face-washing to develop a standard definition of a clean face for monitoring trachoma control programmes.

Jonathan D King1, Jeremiah Ngondi, Jennifer Kasten, Mamadou O Diallo, Huiqing Zhu, Elizabeth A Cromwell, Paul M Emerson.   

Abstract

Surgery, antibiotics, facial cleanliness and environmental improvements (SAFE) are recommended for trachoma control. Programmes assess clean faces in children, but no standard definition of a clean face exists. We conducted a randomised controlled trial of face-washing to develop a valid and repeatable definition of a clean face. A total of 424 children were randomised to washed and unwashed groups after a first observation. Three additional observations were made throughout the day. Photographs were taken at each observation. No difference was observed in wet nasal discharge, dust, food or flies on the face between the face washed and unwashed groups at baseline or after washing. A difference was observed in the presence of ocular discharge (P < 0.001) and dry nasal discharge (P < 0.001) after washing. Agreement among observers was highest for flies (Kappa = 0.89, 95% CI = 0.87-0.91), followed by nasal (Kappa = 0.64, 0.62-0.66) and ocular (Kappa = 0.48, 0.46-0.50) discharge. The ability of any definition to identify whether a face had been washed decreased at each observation. This study suggests that the absence of ocular and dry nasal discharge can be used as an indicator of 'clean face', although it is not a good predictor of whether a face has been washed and is difficult to recommend.
Copyright © 2010 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21036378     DOI: 10.1016/j.trstmh.2010.09.008

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  24 in total

Review 1.  Prevention and control of neglected tropical diseases: overview of randomized trials, systematic reviews and meta-analyses.

Authors:  Shanthi Kappagoda; John P A Ioannidis
Journal:  Bull World Health Organ       Date:  2014-03-13       Impact factor: 9.408

Review 2.  Face washing promotion for preventing active trachoma.

Authors:  Henry O D Ejere; Mahmoud B Alhassan; Mansur Rabiu
Journal:  Cochrane Database Syst Rev       Date:  2015-02-20

Review 3.  Face washing promotion for preventing active trachoma.

Authors:  Henry O D Ejere; Mahmoud B Alhassan; Mansur Rabiu
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

Review 4.  Trachoma.

Authors:  Anthony W Solomon; Matthew J Burton; Emily W Gower; Emma M Harding-Esch; Catherine E Oldenburg; Hugh R Taylor; Lamine Traoré
Journal:  Nat Rev Dis Primers       Date:  2022-05-26       Impact factor: 52.329

5.  Risk factors for ocular chlamydia after three mass azithromycin distributions.

Authors:  Berhan Ayele; Teshome Gebre; Jeanne Moncada; Jenafir I House; Nicole E Stoller; Zhaoxia Zhou; Travis C Porco; Bruce D Gaynor; Paul M Emerson; Julius Schachter; Jeremy D Keenan
Journal:  PLoS Negl Trop Dis       Date:  2011-12-13

Review 6.  Will the SAFE strategy be sufficient to eliminate trachoma by 2020? Puzzlements and possible solutions.

Authors:  Diane K Lavett; Van C Lansingh; Marissa J Carter; Kristen A Eckert; Juan C Silva
Journal:  ScientificWorldJournal       Date:  2013-05-19

Review 7.  Effect of water, sanitation, and hygiene on the prevention of trachoma: a systematic review and meta-analysis.

Authors:  Meredith E Stocks; Stephanie Ogden; Danny Haddad; David G Addiss; Courtney McGuire; Matthew C Freeman
Journal:  PLoS Med       Date:  2014-02-25       Impact factor: 11.069

8.  The limits of medical interventions for the elimination of preventable blindness.

Authors:  Pablo Goldschmidt; Ellen Einterz
Journal:  Trop Med Health       Date:  2014-02-18

9.  Prevalence of trachoma at sub-district level in ethiopia: determining when to stop mass azithromycin distribution.

Authors:  Jonathan D King; Tesfaye Teferi; Elizabeth A Cromwell; Mulat Zerihun; Jeremiah M Ngondi; Mesele Damte; Frew Ayalew; Zerihun Tadesse; Teshome Gebre; Ayelign Mulualem; Alemu Karie; Berhanu Melak; Mitku Adugna; Demelash Gessesse; Abebe Worku; Tekola Endashaw; Fisseha Admassu Ayele; Nicole E Stoller; Mary Rose A King; Aryc W Mosher; Tesfaye Gebregzabher; Geremew Haileysus; Peter Odermatt; Jürg Utzinger; Paul M Emerson
Journal:  PLoS Negl Trop Dis       Date:  2014-03-13

10.  Relationship between Community Drug Administration Strategy and Changes in Trachoma Prevalence, 2007 to 2013.

Authors:  Bette Liu; Carleigh Cowling; Andrew Hayen; Gabrielle Watt; Donna B Mak; Stephen Lambert; Hugh Taylor; John M Kaldor
Journal:  PLoS Negl Trop Dis       Date:  2016-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.